SG11202004691WA - Complex for genome editing having stability and few side-effects, and nucleic acid coding same - Google Patents

Complex for genome editing having stability and few side-effects, and nucleic acid coding same

Info

Publication number
SG11202004691WA
SG11202004691WA SG11202004691WA SG11202004691WA SG11202004691WA SG 11202004691W A SG11202004691W A SG 11202004691WA SG 11202004691W A SG11202004691W A SG 11202004691WA SG 11202004691W A SG11202004691W A SG 11202004691WA SG 11202004691W A SG11202004691W A SG 11202004691WA
Authority
SG
Singapore
Prior art keywords
complex
stability
effects
nucleic acid
genome editing
Prior art date
Application number
SG11202004691WA
Other languages
English (en)
Inventor
Keiji Nishida
Original Assignee
Univ Kobe Nat Univ Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Kobe Nat Univ Corp filed Critical Univ Kobe Nat Univ Corp
Publication of SG11202004691WA publication Critical patent/SG11202004691WA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases RNAses, DNAses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2497—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing N- glycosyl compounds (3.2.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/02—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2) hydrolysing N-glycosyl compounds (3.2.2)
    • C12Y302/02027—Uracil-DNA glycosylase (3.2.2.27)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
    • C12Y305/04—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in cyclic amidines (3.5.4)
    • C12Y305/04005—Cytidine deaminase (3.5.4.5)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/95—Fusion polypeptide containing a motif/fusion for degradation (ubiquitin fusions, PEST sequence)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Mycology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
SG11202004691WA 2017-11-22 2018-11-21 Complex for genome editing having stability and few side-effects, and nucleic acid coding same SG11202004691WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017225221 2017-11-22
PCT/JP2018/042915 WO2019103020A1 (ja) 2017-11-22 2018-11-21 安定で副作用の少ないゲノム編集用複合体及びそれをコードする核酸

Publications (1)

Publication Number Publication Date
SG11202004691WA true SG11202004691WA (en) 2020-06-29

Family

ID=66632001

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202004691WA SG11202004691WA (en) 2017-11-22 2018-11-21 Complex for genome editing having stability and few side-effects, and nucleic acid coding same

Country Status (9)

Country Link
US (1) US20210024906A1 (ja)
EP (1) EP3715454A4 (ja)
JP (2) JP7328695B2 (ja)
KR (1) KR102387830B1 (ja)
CN (1) CN111615557A (ja)
BR (1) BR112020010036A2 (ja)
CA (1) CA3082922C (ja)
SG (1) SG11202004691WA (ja)
WO (1) WO2019103020A1 (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7133856B2 (ja) * 2017-03-22 2022-09-09 国立大学法人神戸大学 細胞内在性のｄｎａ修飾酵素を利用して標的化したｄｎａの核酸塩基を特異的に変換する、細胞の核酸配列の変換方法、及びそれに用いる分子複合体
WO2022095929A1 (en) * 2020-11-06 2022-05-12 The University Of Hong Kong Transferable type i-f crispr-cas genome editing system
CN116555227B (zh) * 2021-02-03 2024-08-06 山东舜丰生物科技有限公司 新型Cas酶以及应用
CN113862274B (zh) * 2021-09-29 2023-10-03 燕山大学 一种高特异性识别ape1的寡核苷酸适配体apt-d1及其制备方法和应用
CN116064429B (zh) * 2022-08-04 2023-11-03 四川省畜牧科学研究院 一种重组大肠杆菌高效表达漆酶的方法
WO2024094084A1 (en) * 2022-11-01 2024-05-10 Huidagene Therapeutics Co., Ltd. Iscb polypeptides and uses thereof
CN117947054B (zh) * 2024-03-25 2024-06-21 上海羽冠生物技术有限公司 一种百日咳鲍特菌无缝基因编辑的方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003251286B2 (en) 2002-01-23 2007-08-16 The University Of Utah Research Foundation Targeted chromosomal mutagenesis using zinc finger nucleases
JP2013128413A (ja) 2010-03-11 2013-07-04 Kyushu Univ Ｐｐｒモチーフを利用したｒｎａ結合性蛋白質の改変方法
CN104010660A (zh) 2011-10-04 2014-08-27 株式会社Ihi 金属Salen配位化合物响应性药剂以及金属Salen配位化合物的体内行为控制系统
CN111471675A (zh) 2014-03-05 2020-07-31 国立大学法人神户大学 特异性转变靶向dna序列的核酸碱基的基因组序列的修饰方法、及其使用的分子复合体
AU2015324935B2 (en) * 2014-10-01 2021-04-08 The General Hospital Corporation Methods for increasing efficiency of nuclease-induced homology-directed repair
JP6153180B2 (ja) 2014-11-04 2017-06-28 国立大学法人神戸大学 脱塩基反応により標的化したｄｎａ配列に特異的に変異を導入する、ゲノム配列の改変方法、並びにそれに用いる分子複合体
CN104531632A (zh) * 2014-11-18 2015-04-22 李云英 快速降解的Cas9-ODC422-461融合蛋白及其应用
US20160362667A1 (en) * 2015-06-10 2016-12-15 Caribou Biosciences, Inc. CRISPR-Cas Compositions and Methods
CN109536474A (zh) * 2015-06-18 2019-03-29 布罗德研究所有限公司 降低脱靶效应的crispr酶突变
JP6909475B2 (ja) 2016-06-14 2021-07-28 有限会社メカノトランスフォーマ アクチュエータおよび伸縮素子のリード線引き出し方法
US10465187B2 (en) * 2017-02-06 2019-11-05 Trustees Of Boston University Integrated system for programmable DNA methylation
WO2018226880A1 (en) * 2017-06-06 2018-12-13 Zymergen Inc. A htp genomic engineering platform for improving escherichia coli

Also Published As

Publication number Publication date
JPWO2019103020A1 (ja) 2021-01-21
WO2019103020A1 (ja) 2019-05-31
EP3715454A1 (en) 2020-09-30
BR112020010036A2 (pt) 2020-10-20
CN111615557A (zh) 2020-09-01
CA3082922A1 (en) 2019-05-31
CA3082922C (en) 2024-02-13
KR20200091884A (ko) 2020-07-31
EP3715454A4 (en) 2021-08-18
US20210024906A1 (en) 2021-01-28
JP2023129709A (ja) 2023-09-14
JP7328695B2 (ja) 2023-08-17
KR102387830B1 (ko) 2022-04-18

Similar Documents

Publication Publication Date Title
IL273307A (en) Polynucleotides, preparations, and methods for genome editing
SG11202004691WA (en) Complex for genome editing having stability and few side-effects, and nucleic acid coding same
HK1254230A1 (zh) Tat誘導的基於crispr/核酸內切酶的基因編輯
EP3692145A4 (en) NUCLEIC ACID TARGETED EDITING SYSTEMS, METHODS AND COMPOSITIONS
EP3684397A4 (en) SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETED EDITION OF NUCLEIC ACIDS
EP3701025A4 (en) SYSTEMS, PROCEDURES AND COMPOSITIONS FOR TARGETED NUCLEIC ACID EDITING
EP3625340A4 (en) GENOME EDITING SYSTEM
PH12018501159A1 (en) Composition and methods for immunooncology
EP3701042A4 (en) SYSTEMS, PROCEDURES AND COMPOSITIONS FOR TARGETED NUCLEIC ACID EDITING
EP3469084A4 (en) HIGHLY SPECIFIC GENOMEDITATION BY CHEMICALLY MODIFIED GUIDE RNAS
EP3303585A4 (en) Dna editing using single-stranded dna
IL269456A (en) Genomic stability profiling
EP3500271A4 (en) GENOME EDITING ACTIVATORS
HK1248284A1 (zh) 多重乳液核酸擴增
EP3353309A4 (en) COMPOSITIONS AND METHOD FOR GENERIC EDITING
EP3302575A4 (en) GENOME EDITION VECTORS
EP3487992A4 (en) METHODS AND COMPOSITIONS FOR MODIFYING GENOMIC DNA
EP3224363A4 (en) Nucleic acid constructs for genome editing
EP3348636A4 (en) METHOD FOR MODIFYING A GENOME SEQUENCE THAT SPECIFICALLY TRANSVERS THE NUCLEOBASE OF A TARGETED DNA SEQUENCE, AND MOLECULAR COMPLEX USED IN THIS PROCESS
EP3353298A4 (en) ALLELECTIVE GENETIZATION AND USES THEREOF
EP3630350A4 (en) HOMOPOLYMIC ENCODED NUCLEIC ACID STORAGE
EP3316676A4 (en) Haploid inducer line for accelerated genome editing
IL271239A (en) A method for developing nucleic acids
EP3186375A4 (en) NEW CAS9 PROTEINS AND GUIDING ELEMENTS FOR DNA TARGETING AND THE GENOME EDITION
EP3521430A4 (en) DOUBLE-STRANDED NUCLEIC ACID COMPLEX WITH OVERHEAD